Polynovo Ltd (PNV) - Net Assets

Latest as of June 2025: AU$83.26 Million AUD ≈ $58.91 Million USD

Based on the latest financial reports, Polynovo Ltd (PNV) has net assets worth AU$83.26 Million AUD (≈ $58.91 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$127.41 Million ≈ $90.15 Million USD) and total liabilities (AU$44.15 Million ≈ $31.24 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PNV asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$83.26 Million
% of Total Assets 65.35%
Annual Growth Rate 10.2%
5-Year Change 272.5%
10-Year Change 450.98%
Growth Volatility 74.24

Polynovo Ltd - Net Assets Trend (1999–2025)

This chart illustrates how Polynovo Ltd's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Polynovo Ltd for the complete picture of this company's asset base.

Annual Net Assets for Polynovo Ltd (1999–2025)

The table below shows the annual net assets of Polynovo Ltd from 1999 to 2025. For live valuation and market cap data, see PNV market cap.

Year Net Assets Change
2025-06-30 AU$83.26 Million
≈ $58.91 Million		 +15.44%
2024-06-30 AU$72.12 Million
≈ $51.03 Million		 +10.31%
2023-06-30 AU$65.38 Million
≈ $46.26 Million		 +269.08%
2022-06-30 AU$17.72 Million
≈ $12.53 Million		 -20.75%
2021-06-30 AU$22.35 Million
≈ $15.82 Million		 -6.13%
2020-06-30 AU$23.81 Million
≈ $16.85 Million		 -8.76%
2019-06-30 AU$26.10 Million
≈ $18.47 Million		 -8.29%
2018-06-30 AU$28.46 Million
≈ $20.14 Million		 +163.20%
2017-06-30 AU$10.81 Million
≈ $7.65 Million		 -28.45%
2016-06-30 AU$15.11 Million
≈ $10.69 Million		 +104.40%
2015-06-30 AU$7.39 Million
≈ $5.23 Million		 -14.71%
2014-06-30 AU$8.67 Million
≈ $6.13 Million		 +10.87%
2013-06-30 AU$7.82 Million
≈ $5.53 Million		 -2.14%
2012-06-30 AU$7.99 Million
≈ $5.65 Million		 -24.92%
2011-06-30 AU$10.64 Million
≈ $7.53 Million		 -22.57%
2010-06-30 AU$13.74 Million
≈ $9.72 Million		 -13.15%
2009-06-30 AU$15.82 Million
≈ $11.20 Million		 -3.88%
2008-06-30 AU$16.46 Million
≈ $11.65 Million		 -20.81%
2007-06-30 AU$20.79 Million
≈ $14.71 Million		 -8.68%
2006-06-30 AU$22.76 Million
≈ $16.11 Million		 +31.73%
2005-06-30 AU$17.28 Million
≈ $12.23 Million		 +3.58%
2004-06-30 AU$16.68 Million
≈ $11.81 Million		 +166.47%
2003-06-30 AU$6.26 Million
≈ $4.43 Million		 -48.46%
2002-06-30 AU$12.15 Million
≈ $8.60 Million		 +89.58%
2001-06-30 AU$6.41 Million
≈ $4.53 Million		 -44.07%
2000-06-30 AU$11.46 Million
≈ $8.11 Million		 +72.17%
1999-06-30 AU$6.66 Million
≈ $4.71 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Polynovo Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 10126735800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$191.76 Million 230.31%
Other Comprehensive Income AU$-5.59 Million -6.72%
Total Equity AU$83.26 Million 100.00%

Polynovo Ltd Competitors by Market Cap

The table below lists competitors of Polynovo Ltd ranked by their market capitalization.

Company Market Cap
Sygnity SA
WAR:SGN
 $486.86 Million
Chularat Hospital Public Company Limited
BK:CHG
 $486.86 Million
Shui On Land Limited
F:OL5
 $486.93 Million
enGene Holdings Inc. Common Stock
NASDAQ:ENGN
 $487.01 Million
Ningbo David Medical Device Co Ltd
SHE:300314
 $486.34 Million
Ege Profil Ticaret ve Sanayi AS
IS:EGPRO
 $486.31 Million
Shenzhen Ecobeauty Co Ltd
SHE:000010
 $486.19 Million
Shanxi Antai Group Co Ltd
SHG:600408
 $486.18 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Polynovo Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 72,124,000 to 83,262,000, a change of 11,138,000 (15.4%).
  • Net income of 13,214,000 contributed positively to equity growth.
  • Other comprehensive income decreased equity by 2,233,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$13.21 Million +15.87%
Other Comprehensive Income AU$-2.23 Million -2.68%
Other Changes AU$157.00K +0.19%
Total Change AU$- 15.44%

Book Value vs Market Value Analysis

This analysis compares Polynovo Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 8.36x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 0.22x to 8.36x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1999-06-30 AU$4.46 AU$1.00 x
2000-06-30 AU$0.62 AU$1.00 x
2001-06-30 AU$0.32 AU$1.00 x
2002-06-30 AU$0.57 AU$1.00 x
2003-06-30 AU$0.27 AU$1.00 x
2004-06-30 AU$0.08 AU$1.00 x
2005-06-30 AU$0.08 AU$1.00 x
2006-06-30 AU$0.09 AU$1.00 x
2007-06-30 AU$0.07 AU$1.00 x
2008-06-30 AU$0.05 AU$1.00 x
2009-06-30 AU$0.05 AU$1.00 x
2010-06-30 AU$0.04 AU$1.00 x
2011-06-30 AU$0.03 AU$1.00 x
2012-06-30 AU$0.02 AU$1.00 x
2013-06-30 AU$0.02 AU$1.00 x
2014-06-30 AU$0.02 AU$1.00 x
2015-06-30 AU$0.02 AU$1.00 x
2016-06-30 AU$0.03 AU$1.00 x
2017-06-30 AU$0.02 AU$1.00 x
2018-06-30 AU$0.05 AU$1.00 x
2019-06-30 AU$0.04 AU$1.00 x
2020-06-30 AU$0.04 AU$1.00 x
2021-06-30 AU$0.03 AU$1.00 x
2022-06-30 AU$0.03 AU$1.00 x
2023-06-30 AU$0.10 AU$1.00 x
2024-06-30 AU$0.10 AU$1.00 x
2025-06-30 AU$0.12 AU$1.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Polynovo Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 15.87%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 10.38%
  • • Asset Turnover: 1.00x
  • • Equity Multiplier: 1.53x
  • Recent ROE (15.87%) is above the historical average (-32.05%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 -24.58% 0.00% 0.00x 1.06x AU$-2.30 Million
2000 -31.10% -693.19% 0.04x 1.04x AU$-4.71 Million
2001 -79.13% -1043.42% 0.07x 1.13x AU$-5.71 Million
2002 -47.17% -1528.27% 0.03x 1.04x AU$-6.95 Million
2003 -136.87% -1464.96% 0.08x 1.19x AU$-9.20 Million
2004 -57.20% -1141626.79% 0.00x 1.12x AU$-11.21 Million
2005 -62.29% 0.00% 0.00x 1.08x AU$-12.49 Million
2006 -49.61% -6344943.82% 0.00x 1.10x AU$-13.57 Million
2007 -64.49% -307077.42% 0.00x 1.06x AU$-15.49 Million
2008 -26.98% 0.00% 0.00x 1.04x AU$-6.09 Million
2009 -12.54% 0.00% 0.00x 1.19x AU$-3.29 Million
2010 -13.54% -1527.36% 0.01x 1.09x AU$-3.24 Million
2011 -27.32% -751.41% 0.03x 1.10x AU$-3.98 Million
2012 -33.62% -1116.97% 0.03x 1.11x AU$-3.50 Million
2013 -18.98% -1325.46% 0.01x 1.10x AU$-2.28 Million
2014 -33.68% -4877.40% 0.01x 1.08x AU$-3.81 Million
2015 -17.23% -5828.37% 0.00x 1.08x AU$-2.06 Million
2016 -20.26% -93.44% 0.20x 1.06x AU$-4.57 Million
2017 -46.30% -138.29% 0.30x 1.11x AU$-6.09 Million
2018 -20.99% -91.15% 0.22x 1.05x AU$-8.82 Million
2019 -12.22% -22.71% 0.50x 1.08x AU$-5.80 Million
2020 -17.61% -18.93% 0.59x 1.59x AU$-6.58 Million
2021 -20.60% -15.79% 0.76x 1.72x AU$-6.84 Million
2022 -6.73% -2.88% 1.18x 1.97x AU$-2.96 Million
2023 -7.53% -7.55% 0.70x 1.42x AU$-11.46 Million
2024 7.29% 5.10% 0.95x 1.51x AU$-1.95 Million
2025 15.87% 10.38% 1.00x 1.53x AU$4.89 Million

Industry Comparison

This section compares Polynovo Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $61,040,828
  • Average return on equity (ROE) among peers: -33.85%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Polynovo Ltd (PNV) AU$83.26 Million -24.58% 0.53x $486.37 Million
4DMEDICAL Ltd (4DX) $64.24 Million -46.81% 0.48x $1.63 Billion
Adherium Ltd (ADR) $-4.76 Million 0.00% 0.00x $7.37 Million
Aroa Biosurgery Ltd (ARX) $6.92 Million -23.35% 0.08x $150.91 Million
Atomo Diagnostics Ltd (AT1) $-5.47 Million 0.00% 0.00x $13.76 Million
Avita Medical Inc (AVH) $5.12 Million -224.74% 0.50x $132.15 Million
Anteris Technologies Global Corp (AVR) $22.64 Million -106.07% 0.18x $570.83 Million
Control Bionics Ltd (CBL) $5.05 Million -38.22% 0.07x $18.95 Million
Cardiex Ltd (CDX) $4.88 Million 56.04% 0.31x $13.23 Million
Compumedics Ltd (CMP) $8.51 Million 8.89% 1.37x $41.70 Million
Cochlear Ltd (COH) $503.28 Million 35.79% 0.47x $4.60 Billion

About Polynovo Ltd

AU:PNV Australia Medical Devices
Market Cap
$486.37 Million
AU$687.39 Million AUD
Market Cap Rank
#12696 Global
#321 in Australia
Share Price
AU$1.00
Change (1 day)
-0.50%
52-Week Range
AU$0.88 - AU$1.67
All Time High
AU$4.01
Categories
Companies in Australia Medical Devices
About

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more